Allison Betof Warner/X
Jan 14, 2025, 13:28
Allison Betof Warner: Another landmark day for solid tumor cell therapy at Stanford Cancer Institute
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford Cancer Institute, posted on X:
“Another landmark day for solid tumor cell therapy at Stanford Cancer Institute with our first infusion of FDA approved afami-cel (Tecelra), an engineered TCR T cell therapy for synovial sarcoma. We are thrilled to make this available to our patients!!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 2, 2025, 18:07
Jun 2, 2025, 18:00
Jun 2, 2025, 17:43
Jun 2, 2025, 17:18
Jun 2, 2025, 17:06
Jun 2, 2025, 15:40